Skip to main content
. 2019 Apr 10;17(2):98–103. doi: 10.1176/appi.focus.20180038

FIGURE 1.

FIGURE 1.

Pathway for the effective treatment of cannabis use disordera

aNAC, N-acetylcysteine; CB1, cannabinoid receptor type 1; GAD, generalized anxiety disorder; SAD, social anxiety disorder; MDD, major depressive disorder; PTSD, posttraumatic stress disorder; ADHD, attention-deficit hyperactivity disorder